Sponsored Session: How RECCE 327 is Leading the Way as a Potential Robust Solution to Sepsis and Superbugs
Sponsored by Recce
Recce’s new class of synthetic anti-infectives, including RECCE 327, have a universal mechanism of action with the ability to overcome hyper-cellular mutation of bacteria and viruses. In this sponsored session, learners will review the unique qualities of Recce anti-infectives, including that their potency does not diminish even with repeated use. Learners will also review the ways in which Recce Pharmaceuticals continues to strengthen and expand its product pipeline of therapeutic options for ‘difficult to treat’ bacterial and viral infections.
This session was originally recorded in September 2022 as part of Sepsis Alliance Summit.
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Sepsis Alliance gratefully acknowledges the support provided for this session by Recce PHarmaceuticals.
Chief Executive Officer, Recce Pharmaceuticals
James Graham is the Chief Executive Officer of Recce Pharmaceuticals. Mr. Graham has a background in marketing, business development, and commercialization of early-stage technologies with global potential. Mr. Graham is leading Recce on a successful growth path as an emerging global health leader in synthetic anti-infectives by pioneering the development and commercialization of new classes of synthetic anti-infectives. Mr. Graham has invested in almost every capital raise to date, demonstrating great dedication and drive and expanding Recce’s commercial opportunities and clinical initiatives.
No continuing education credits are offered for this session. Content is provided by the sponsor.
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.